A number of factors such as histological grade, type and size of tumor, lymph node metastasis, estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2/neu), influence the prognosis and response to the treatment of cancer. Here, ERBB2 is linked to metastatic malignant neoplasm in the lymph nodes.